Treatment Methods for Cerebral Lacunar Infarction

As China enters an aging society, an increasing number of people are developing cerebral infarction. Many individuals who suffer from cerebral infarction experience sequelae such as memory decline, slowed reaction time, slurred speech, and impaired motor function—significantly affecting their quality of life. So, what are the treatment options for lacunar cerebral infarction?

Treatment Options for Lacunar Cerebral Infarction

Treatment for lacunar cerebral infarction is limited to preventive or secondary preventive strategies. Since lacunar infarcts predominantly occur in middle-aged and elderly individuals and are closely associated with atherosclerosis, they often remain asymptomatic in early stages and may therefore be easily overlooked. Antiplatelet therapy—including long-term use of aspirin, clopidogrel, and other agents—is recommended. Antiatherosclerotic treatment is also essential: many patients have hypercholesterolemia, which accelerates atherosclerosis, necessitating lipid-lowering therapy. Blood pressure management is critical as well, since hypertension commonly coexists with lacunar infarction; thus, antihypertensive treatment is required.

Lacunar cerebral infarction has drawn attention from numerous individuals. The etiology of this condition is complex, primarily involving damage to brain health—often causing severe impairment to cerebral function, accompanied by symptoms such as dizziness and fatigue, which adversely affect patients’ daily life and work performance. Close monitoring of cerebral changes is essential. Active treatment of cerebral edema is warranted, including timely administration of dehydrating agents or diuretics to improve microcirculation. Under physician guidance, low-molecular-weight dextran can effectively reduce blood viscosity and significantly improve microcirculation, yielding satisfactory clinical outcomes.

Patients are advised to take calcium channel blockers (e.g., aspirin, though note: aspirin is not a calcium channel blocker—this may be an error in the original text; likely intended to refer to calcium antagonists such as nimodipine) per their physician’s recommendation to effectively relieve vasospasm and reduce disease recurrence. We hope this information proves helpful.